# Dyne Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/dyne-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 21 | | Claims under review | 1 | | Evidence records | 6 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-19T14:43:40.33645+00:00 | | Last reviewed | 2026-10-19T14:43:40.33645+00:00 | ## Identity - Legal name: Dyne Therapeutics, Inc. - Display name: Dyne Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-19T21:45:52.148359+00:00 | | Completeness | 0.409 | | Record Quality | 0.839 | | Directors | 10 | | Committees | 1 | | Governance events | 11 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Brian Posner: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-01-01. claim_id=alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:6 - Carlo Incerti: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2022-01-01. claim_id=alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:7 - Catherine Stehman-Breen: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2019-01-01. claim_id=alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:8 - David Lubner: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:9 - Dirk Kersten: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. claim_id=alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:10 - Edward Hurwitz: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. claim_id=alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:11 - Johanna Friedl-Naderer: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-23. claim_id=alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:12 - Vikram Karnani: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-01-01. claim_id=alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:14 - Jason Rhodes: Chairman of the Board. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:5 - John G. Cox: Chief Executive Officer, President and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: President and Director (member). claim_id=alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:13 ## Committees - President and Director (other). Chair: NOT_PUBLISHED. Members: John G. Cox (member, unknown). committee_id=alpha:committee:dyne-therapeutics-inc:president-and-director ## Executive leadership - Jeremy K. Cox: Chief Executive Officer, President and Director [CEO]. Status: current. claim_id=alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:17 - Oxana Beskrovnaya: Chief Innovation Officer. Status: current. claim_id=alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:20 - Richard Scalzo: Senior Vice President, Head of Finance and Administration. Status: current. claim_id=alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:21 - Douglas Kerr: Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:15 - Erick Lucera: Chief Financial Officer and Treasurer [CFO]. Status: unknown. claim_id=alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:16 - Johanna Friedl-Naderer: Chief Commercial Officer. Status: unknown. claim_id=alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:18 - John G. Cox: Chief Executive Officer and President [CEO]. Status: unknown. claim_id=alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:19 ## Governance events - DIRECTOR_APPOINTED: Johanna Friedl-Naderer seat on Dyne Therapeutics, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-19T14:43:40.33645+00:00. event_id=alpha:event:transition:tdadd01et3crc - CEO_CHANGED: Jeremy K. Cox executive of Dyne Therapeutics, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-19T14:43:40.33645+00:00. event_id=alpha:event:transition:q2jk251b98dxj - EXECUTIVE_APPOINTED: Oxana Beskrovnaya executive of Dyne Therapeutics, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-19T14:43:40.33645+00:00. event_id=alpha:event:transition:uhwznzkzrfj - EXECUTIVE_APPOINTED: Richard Scalzo executive of Dyne Therapeutics, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-19T14:43:40.33645+00:00. event_id=alpha:event:transition:1qtx35goly2by - DIRECTOR_APPOINTED: Brian Posner seat on Dyne Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-19T14:43:40.33645+00:00. event_id=alpha:event:transition:1nhj3jl16116yv - DIRECTOR_APPOINTED: Vikram Karnani seat on Dyne Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-19T14:43:40.33645+00:00. event_id=alpha:event:transition:5tjn8y1piy9gc - DIRECTOR_APPOINTED: Carlo Incerti seat on Dyne Therapeutics, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-19T14:43:40.33645+00:00. event_id=alpha:event:transition:wrpcf11hzclhp - DIRECTOR_APPOINTED: David Lubner seat on Dyne Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-19T14:43:40.33645+00:00. event_id=alpha:event:transition:jivqdp1sk7u7d - DIRECTOR_APPOINTED: Catherine Stehman-Breen seat on Dyne Therapeutics, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-19T14:43:40.33645+00:00. event_id=alpha:event:transition:1cqb9f4156oaam - DIRECTOR_APPOINTED: Dirk Kersten seat on Dyne Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-19T14:43:40.33645+00:00. event_id=alpha:event:transition:13z29fu13ljqqi - DIRECTOR_APPOINTED: Edward Hurwitz seat on Dyne Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-19T14:43:40.33645+00:00. event_id=alpha:event:transition:r3i99tx2e7pb ## Scoped resources - `alpha://company/dyne-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=record - `alpha://company/dyne-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=record§ion=identity - `alpha://company/dyne-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/dyne-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=record§ion=board - `alpha://company/dyne-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=record§ion=committees - `alpha://company/dyne-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=record§ion=leadership - `alpha://company/dyne-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=record§ion=ownership - `alpha://company/dyne-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=record§ion=financials - `alpha://company/dyne-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/dyne-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=record§ion=compensation - `alpha://company/dyne-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=record§ion=governance - `alpha://company/dyne-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/dyne-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=record§ion=audit - `alpha://company/dyne-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=record§ion=legal - `alpha://company/dyne-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=record§ion=risk - `alpha://company/dyne-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=record§ion=cyber - `alpha://company/dyne-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/dyne-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=record§ion=agents - `alpha://company/dyne-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/dyne-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=record§ion=events - `alpha://company/dyne-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=record§ion=relationships - `alpha://company/dyne-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=record§ion=assessments - `alpha://company/dyne-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Jason Rhodes: Chairman of the Board. Claim: alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9e8bdd9720c7a60eeb6153299ee67a2af5d5595f8cd4c6925dac44f4b69e7372. - Brian Posner: Director. Claim: alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:6. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e7a749cbdc1ecfc2d17d27c7bfd6fcf13891c701daa9068daaa854719de6ea01. - Carlo Incerti: Director. Claim: alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:7. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e7a749cbdc1ecfc2d17d27c7bfd6fcf13891c701daa9068daaa854719de6ea01. - Catherine Stehman-Breen: Director. Claim: alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:8. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e7a749cbdc1ecfc2d17d27c7bfd6fcf13891c701daa9068daaa854719de6ea01. - David Lubner: Director. Claim: alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:9. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e7a749cbdc1ecfc2d17d27c7bfd6fcf13891c701daa9068daaa854719de6ea01. - Dirk Kersten: Director. Claim: alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:10. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e7a749cbdc1ecfc2d17d27c7bfd6fcf13891c701daa9068daaa854719de6ea01. - Edward Hurwitz: Director. Claim: alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:11. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e7a749cbdc1ecfc2d17d27c7bfd6fcf13891c701daa9068daaa854719de6ea01. - Johanna Friedl-Naderer: Director. Claim: alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:12. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e7a749cbdc1ecfc2d17d27c7bfd6fcf13891c701daa9068daaa854719de6ea01. - John G. Cox: Chief Executive Officer, President and Director. Claim: alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9e8bdd9720c7a60eeb6153299ee67a2af5d5595f8cd4c6925dac44f4b69e7372. - Vikram Karnani: Director. Claim: alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:14. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e7a749cbdc1ecfc2d17d27c7bfd6fcf13891c701daa9068daaa854719de6ea01. - Douglas Kerr: Chief Medical Officer. Claim: alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9e8bdd9720c7a60eeb6153299ee67a2af5d5595f8cd4c6925dac44f4b69e7372. - Erick Lucera: Chief Financial Officer and Treasurer. Claim: alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9e8bdd9720c7a60eeb6153299ee67a2af5d5595f8cd4c6925dac44f4b69e7372. - Jeremy K. Cox: Chief Executive Officer, President and Director. Claim: alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:17. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:929aa79ead5df182d04c45334d15be8570bb4c7e8acea2001a54ab19487a5db7. - Johanna Friedl-Naderer: Chief Commercial Officer. Claim: alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9e8bdd9720c7a60eeb6153299ee67a2af5d5595f8cd4c6925dac44f4b69e7372. - John G. Cox: Chief Executive Officer and President. Claim: alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9e8bdd9720c7a60eeb6153299ee67a2af5d5595f8cd4c6925dac44f4b69e7372. - Oxana Beskrovnaya: Chief Innovation Officer. Claim: alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:20. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f2b1e270eb9674ccb9efa3fb5c0edde8811bea2114f8bde76056ec70b5f5673b. - Richard Scalzo: Senior Vice President, Head of Finance and Administration. Claim: alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:leadership_role:21. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:37b9319087234cf22f5590c0be7710519eec2b87280c8553651ca8610bb0c18e. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Dyne Therapeutics, Inc.. Claim: alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1ab73243a07ede89a1c940fa584e4b48571532312ae4888235341bed84681ec2. ## Entity Status - Public listing published. Claim: alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1ab73243a07ede89a1c940fa584e4b48571532312ae4888235341bed84681ec2. ## Published Fact - US. Claim: alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1ab73243a07ede89a1c940fa584e4b48571532312ae4888235341bed84681ec2. ## Security Listing - DYN (NASDAQ). Claim: alpha:claim:company:39fcbb27-6dcb-41c6-96d6-74d5b66d97d2:security_listing:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1ab73243a07ede89a1c940fa584e4b48571532312ae4888235341bed84681ec2. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:1ab73243a07ede89a1c940fa584e4b48571532312ae4888235341bed84681ec2: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/dyne-therapeutics-inc). - alpha:projection-evidence:document:9e8bdd9720c7a60eeb6153299ee67a2af5d5595f8cd4c6925dac44f4b69e7372: [SEC DEF 14A 0001193125-26-173655](https://www.sec.gov/Archives/edgar/data/1818794/000119312526173655/dyn-20260422.htm). - alpha:projection-evidence:document:e7a749cbdc1ecfc2d17d27c7bfd6fcf13891c701daa9068daaa854719de6ea01: [DEF 14A dyn-20260422.htm](https://www.sec.gov/Archives/edgar/data/1818794/000119312526173655/dyn-20260422.htm). - alpha:projection-evidence:document:929aa79ead5df182d04c45334d15be8570bb4c7e8acea2001a54ab19487a5db7: [DYN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1818794/000119312526173655/dyn-20260422.htm). - alpha:projection-evidence:document:f2b1e270eb9674ccb9efa3fb5c0edde8811bea2114f8bde76056ec70b5f5673b: [DYN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1818794/000119312526173655/dyn-20260422.htm). - alpha:projection-evidence:document:37b9319087234cf22f5590c0be7710519eec2b87280c8553651ca8610bb0c18e: [DYN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1818794/000119312526173655/dyn-20260422.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/dyne-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/dyne-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/dyne-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/dyne-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-19T21:45:51.906111+00:00; recorded 2026-10-19T21:45:51.906111+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.